tiprankstipranks
Immunocellular Therapeutics, Ltd. (IMUC)
:IMUC
US Market

ImmunoCellular Therapeutics (IMUC) Financial Statements

Compare
180 Followers

ImmunoCellular Therapeutics Financial Overview

ImmunoCellular Therapeutics's market cap is currently $17.78M. The company's EPS TTM is $; its P/E ratio is ―; ImmunoCellular Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -1.82M$ -2.89M$ -2.61M$ -1.45M
EBITDA$ -1.06M$ -2.44M$ -1.00$ 0.00
Net Income$ -1.61M$ -2.65M$ -2.68M$ -1.45M
Balance Sheet
Cash & Short-Term Investments$ 278.26K$ 613.24K$ 1.49M$ 262.98K
Total Assets$ 409.42K$ 768.80K$ 1.67M$ 266.70K
Total Debt$ 4.74M$ 3.47M$ 1.37M$ 0.00
Net Debt$ 4.46M$ 2.85M$ -114.10K$ -262.98K
Total Liabilities$ 6.10M$ 4.96M$ 1.84M$ 137.13K
Stockholders' Equity$ -5.69M$ -4.19M$ -171.52K$ 129.58K
Cash Flow
Free Cash Flow$ -1.42M$ -2.62M$ -2.31M$ -1.24M
Operating Cash Flow$ -1.42M$ -2.62M$ -2.31M$ -1.24M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 1.09M$ 1.75M$ 3.53M$ 1.50M
Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History

ImmunoCellular Therapeutics Debt to Assets

ImmunoCellular Therapeutics Cash Flow

ImmunoCellular Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis